181 related articles for article (PubMed ID: 29779010)
1. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
2. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
3. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
5. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.
Theander E; Vasaitis L; Baecklund E; Nordmark G; Warfvinge G; Liedholm R; Brokstad K; Jonsson R; Jonsson MV
Ann Rheum Dis; 2011 Aug; 70(8):1363-8. PubMed ID: 21715359
[TBL] [Abstract][Full Text] [Related]
7. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.
Alevizos I; Alexander S; Turner RJ; Illei GG
Arthritis Rheum; 2011 Feb; 63(2):535-44. PubMed ID: 21280008
[TBL] [Abstract][Full Text] [Related]
9. B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory Study.
Bruno D; Tolusso B; Lugli G; Di Mario C; Petricca L; Perniola S; Bui L; Benvenuto R; Ferraccioli G; Alivernini S; Gremese E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542233
[TBL] [Abstract][Full Text] [Related]
10. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development.
Jordan R; Diss TC; Lench NJ; Isaacson PG; Speight PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):723-9. PubMed ID: 7621030
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
13. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.
Christodoulou MI; Kapsogeorgou EK; Moutsopoulos NM; Moutsopoulos HM
Am J Pathol; 2008 Nov; 173(5):1389-96. PubMed ID: 18818377
[TBL] [Abstract][Full Text] [Related]
14. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
16. High incidence of lymphoid infiltration on labial salivary gland biopsy in non-Hodgkin's lymphomas: clinical implications.
Morel P; Quiquandon I; Janin A; Dupriez B; Desablens B; Gosselin B; Bauters F
Br J Haematol; 1993 Sep; 85(1):93-8. PubMed ID: 8251415
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
18. Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome.
Freimark B; Fantozzi R; Bone R; Bordin G; Fox R
Arthritis Rheum; 1989 Jul; 32(7):859-69. PubMed ID: 2546568
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
[TBL] [Abstract][Full Text] [Related]
20. Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome.
Jonsson MV; Theander E; Jonsson R
Presse Med; 2012 Sep; 41(9 Pt 2):e511-6. PubMed ID: 22867948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
